Synovus Financial Corp Regeneron Pharmaceuticals, Inc. Transaction History

Synovus Financial Corp

  • $7.79 Billion
  • Q4 2024

A detailed history of Synovus Financial Corp transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Synovus Financial Corp holds 1,848 shares of REGN stock, worth $1.24 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,848
Previous 1,881 1.75%
Holding current value
$1.24 Million
Previous $1.98 Million 33.43%
% of portfolio
0.02%
Previous 0.02%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
SELL
$701.85 - $1046.91 $23,161 - $34,548
-33 Reduced 1.75%
1,848 $1.32 Million
Q3 2024

Nov 14, 2024
BUY
$1024.09 - $1201.76 $62,469 - $73,307
61 Added 3.35%
1,881 $1.98 Million
Q2 2024

Aug 13, 2024
BUY
$883.2 - $1071.19 $1,766 - $2,142
2 Added 0.11%
1,820 $1.91 Million
Q1 2024

May 14, 2024
BUY
$902.69 - $993.35 $145,333 - $159,929
161 Added 9.72%
1,818 $1.75 Million
Q3 2023

Nov 13, 2023
BUY
$692.45 - $844.37 $43,624 - $53,195
63 Added 3.95%
1,657 $1.36 Million
Q2 2023

Aug 08, 2023
SELL
$700.03 - $830.35 $63,702 - $75,561
-91 Reduced 5.4%
1,594 $1.15 Million
Q1 2023

May 11, 2023
SELL
$680.49 - $826.97 $207,549 - $252,225
-305 Reduced 15.33%
1,685 $1.38 Million
Q4 2022

Feb 06, 2023
BUY
$705.89 - $766.39 $652,242 - $708,144
924 Added 86.68%
1,990 $1.44 Million
Q3 2022

Oct 27, 2022
BUY
$573.97 - $724.32 $23,532 - $29,697
41 Added 4.0%
1,066 $726,000
Q2 2022

Aug 10, 2022
BUY
$548.35 - $738.84 $23,030 - $31,031
42 Added 4.27%
1,025 $614,000
Q1 2022

May 12, 2022
SELL
$595.12 - $698.43 $3.33 Million - $3.91 Million
-5,600 Reduced 85.07%
983 $679,000
Q4 2021

Feb 14, 2022
BUY
$543.48 - $670.97 $317,935 - $392,517
585 Added 9.75%
6,583 $4.16 Million
Q3 2021

Nov 08, 2021
BUY
$574.03 - $680.96 $2.77 Million - $3.29 Million
4,834 Added 415.29%
5,998 $3.63 Million
Q2 2021

Aug 11, 2021
BUY
$472.8 - $558.54 $1,891 - $2,234
4 Added 0.34%
1,164 $656,000
Q1 2021

May 11, 2021
BUY
$446.73 - $548.2 $36,631 - $44,952
82 Added 7.61%
1,160 $543,000
Q4 2020

Feb 11, 2021
BUY
$478.3 - $607.98 $19,610 - $24,927
41 Added 3.95%
1,078 $503,000
Q3 2020

Nov 09, 2020
SELL
$544.75 - $658.21 $4,902 - $5,923
-9 Reduced 0.86%
1,037 $585,000
Q2 2020

Aug 10, 2020
SELL
$493.32 - $643.92 $28,119 - $36,703
-57 Reduced 5.17%
1,046 $651,000
Q1 2020

Apr 24, 2020
BUY
$336.18 - $494.43 $71,606 - $105,313
213 Added 23.93%
1,103 $525,000
Q4 2019

Feb 06, 2020
BUY
$274.13 - $376.51 $236,300 - $324,551
862 Added 3078.57%
890 $333,000
Q1 2019

May 09, 2019
SELL
$372.08 - $439.57 $14,511 - $17,143
-39 Reduced 58.21%
28 $11,000
Q3 2018

Nov 01, 2018
BUY
$351.14 - $408.51 $13,694 - $15,931
39 Added 139.29%
67 $27,000
Q1 2018

May 07, 2018
BUY
$315.82 - $393.78 $8,842 - $11,025
28 New
28 $10,000

Others Institutions Holding REGN

# of Institutions
1,485
Shares Held
84.8M
Call Options Held
1.51M
Put Options Held
1.48M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $72.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Synovus Financial Corp Portfolio

Follow Synovus Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Synovus Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Synovus Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email